HER2 Positive Metastatic Breast Cancer

Details

Files
Project Status:
Complete
Therapeutic Area:
HER2 Positive Metastatic Breast Cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0016-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted: November 17, 2022
Stakeholder Feedback Deadline: November 24, 2022
Final Report Posted: January 13, 2023